This is a type of lymphoma, which is cancer of the lymphatic system. It happens in people with AIDS (Acquired Immunodeficiency Syndrome). This is a serious form of lymphoma. It often spreads quickly and can affect unusual places in the body. It's linked to the HIV virus.
Every report comes from a Lived member, sent anonymously.
Have you had Chemotherapy infusion for AIDS-Related Lymphoma?
AIDS-related lymphoma is a cancer of the lymph system that develops in a person with HIV. Lymphoma starts in lymphocytes, the white blood cells that normally help fight infection, and AIDS-related lymphomas are almost always non-Hodgkin lymphomas that arise from B cells, one type of lymphocyte. In someone with HIV, a diagnosis of this kind of lymphoma counts as an AIDS diagnosis. For about half of people, HIV or AIDS is diagnosed at the same time as the lymphoma. These lymphomas are aggressive, meaning they grow quickly, and they are usually advanced by the time they are found. The two main types are diffuse large B-cell lymphoma and Burkitt lymphoma. They often appear outside the lymph nodes, in places such as the bone marrow, liver, digestive tract or the membranes around the brain. When the lymphoma starts in the brain or spinal cord, it is called primary central nervous system (CNS) lymphoma, a distinct form that is diagnosed and treated differently. A rarer type, primary effusion lymphoma, grows in the fluid around the lungs, heart or abdomen rather than forming a lump.
The main driver is a weakened immune system. HIV destroys CD4 cells, the lymphocytes that coordinate the body's immune response, and the risk of lymphoma rises as the CD4 count falls. HIV does not infect the B cells that become cancerous. Instead, the loss of immune control lets other viruses that live in B cells push them toward cancer. The most important is Epstein-Barr virus (EBV), a common virus that most adults carry without harm. EBV is found in most AIDS-related lymphomas and in nearly all AIDS-related primary CNS lymphomas. Primary effusion lymphoma is linked to human herpesvirus 8, the same virus that causes Kaposi sarcoma. Effective HIV treatment, called antiretroviral therapy (ART), has sharply reduced how often these lymphomas occur because it lets the immune system recover. People with HIV still have a higher lifetime risk of certain cancers than the general population, even when HIV is well controlled, and the risk is greatest when HIV is undiagnosed or untreated. Forms tied to the deepest immune loss, such as primary CNS lymphoma, have become less common, while Burkitt lymphoma, which occurs at higher CD4 counts, now makes up a larger share. Hodgkin lymphoma is also more common in people with HIV, but it is a separate disease and not one of the AIDS-related lymphomas.
Common symptoms are fever, drenching night sweats and weight loss without a clear cause, sometimes with painless swollen lymph nodes or a feeling of fullness below the ribs. Infections that occur with advanced HIV can cause the same symptoms, so lymphoma is confirmed only by a biopsy: removing all or part of a lymph node, or a sample of another affected tissue, for a pathologist to examine. Laboratory tests on the sample identify the exact type of lymphoma, which guides treatment. Blood tests check blood counts, organ function and lactate dehydrogenase (LDH), an enzyme that is often raised when lymphoma is active. People are tested for HIV if they have not been already, and the CD4 count shows how weakened the immune system is. Hepatitis B and C tests matter as well, because some lymphoma treatments can reactivate a hidden hepatitis B infection. CT and PET scans, and often a bone marrow biopsy, show how far the lymphoma has spread, which is called its stage. Because these lymphomas can reach the brain and spinal cord, a lumbar puncture (spinal tap) may be done to check the fluid around them. When a mass is found in the brain, the main look-alike is toxoplasmosis, a parasitic infection that also occurs with advanced HIV. MRI and PET scans, blood tests for toxoplasma antibodies and testing spinal fluid for EBV help tell them apart, but a brain biopsy is usually needed to confirm lymphoma. Sometimes doctors treat for toxoplasmosis first, because that infection typically improves within one to three weeks of treatment, and recommend a biopsy if it does not.
Treatment works on two fronts at once: the lymphoma and HIV. Antiretroviral therapy restores immune function, lowers the risk of serious infections during cancer treatment and is linked to better lymphoma outcomes. Before modern HIV treatment, chemotherapy doses were often reduced. Today, most people with HIV should receive the same standard, full-dose lymphoma treatment used for people without HIV, and with good HIV control, results can be comparable. Care works best when the HIV and cancer teams plan treatment together. For lymphoma outside the brain, the usual treatment is combination chemotherapy, several cancer drugs given together in repeated cycles, usually with rituximab added. Rituximab (Rituxan, also available as biosimilar versions) is a monoclonal antibody, a laboratory-made immune protein that attaches to a marker called CD20 on B cells and helps destroy them. Adding it to chemotherapy improves response and survival. Widely used regimens are known by abbreviations such as R-CHOP and EPOCH-R, each combining rituximab with four or five chemotherapy drugs, and Burkitt lymphoma may need a more intensive regimen. When the lymphoma is likely to spread to the brain, chemotherapy may also be injected into the spinal fluid (intrathecal chemotherapy). Lymphoma that does not respond or comes back may be treated with high-dose chemotherapy followed by a stem cell transplant, and CAR T-cell therapy, which reprograms a person's own immune cells to attack the lymphoma, has been used successfully in people with HIV. For people well enough to receive it, primary CNS lymphoma is now usually treated with chemotherapy based on high-dose methotrexate, a drug that reaches the brain when given in large doses, often with rituximab and together with HIV treatment. Radiation therapy to the brain is an option when that chemotherapy is not possible. Supportive care is a large part of treatment. Medicines to prevent infections, such as pneumocystis pneumonia and toxoplasmosis, are given when the CD4 count is below 200, and growth factor injections may help white blood cells recover between chemotherapy cycles. Some HIV regimens, particularly those boosted with ritonavir or cobicistat, can interact with certain chemotherapy drugs and make side effects such as nerve damage worse, because these boosters slow the breakdown of other medicines and so raise their levels in the blood. Many current HIV regimens have few such interactions, so the HIV and cancer teams review the regimen together and may adjust it.
Treatment is intensive and is given in cycles, with time between them for the body to recover. Chemotherapy lowers white blood cell counts, and on top of HIV this makes infections the main hazard during treatment. Chemotherapy can also lower the CD4 count further. Taking HIV medicines consistently throughout treatment protects the immune system, and regular blood tests track blood counts, CD4 levels and HIV control. The outlook has improved substantially with modern HIV treatment. Lymphoma treatment is now given with the aim of cure, and for many people with lymphoma outside the brain, results approach those of people without HIV who have the same lymphoma. Outcomes are less favorable when the CD4 count is very low, the lymphoma involves the bone marrow or several sites outside the lymph nodes, the person has had other AIDS-defining illnesses, or everyday activities are already limited by illness. Primary CNS lymphoma remains harder to treat than lymphoma elsewhere. People with HIV still have lower cancer survival overall than the general population, partly because some are given reduced doses or no cancer treatment at all. After treatment, follow-up visits, blood tests and scans check whether the lymphoma has come back. Ongoing HIV care keeps the immune system as strong as possible and lowers the risk of future HIV-related cancers.
For anyone with HIV, unexplained fever, drenching night sweats, weight loss or painless swollen lymph nodes that do not settle deserve a prompt appointment with the HIV care team. Infections can cause the same symptoms, and either cause needs a diagnosis. During lymphoma treatment, call the care team right away for a fever of 100.5°F (38°C) or higher, chills, or other signs of infection such as a new cough or redness and swelling where a catheter enters the skin. Infections during chemotherapy can become life threatening, and medicines that lower a fever can hide one, so ask the team before taking them. A seizure, or sudden weakness or numbness in part of the body, needs emergency care right away: call 911. In someone with HIV or on lymphoma treatment, these can come from lymphoma, an infection or bleeding in the brain, or a stroke. New or worsening confusion, a personality change or a severe new headache needs assessment by the care team the same day.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with AIDS-Related Lymphoma is like, what's helped you, or ask the community a question.